Abstract
Diabetic cranial neuropathies are much less prevalent than other forms of diabetic neuropathy, but the association of cranial neuropathies with diabetes is unequivocal. Overt cranial neuropathies affect less than 1% of diabetic patients, but there is a four to sevenfold increased risk of cranial neuropathies in diabetes. Cranial neuropathies of CNs III, VI, and VII constitute the majority of clinical cases. Certain clinical features, such as pupillary sparing in CN III cranial neuropathy and preserved taste sensation in CN VII cranial neuropathy, favor a diabetic etiology. In general, diabetic cranial neuropathies do not correlate strongly with microvascular complications of diabetes and can present early or at the diagnosis of diabetes. Diabetes also results in CN I, V, VIII, and X cranial neuropathies, the latter resulting in the early manifestations of cardiac autonomic neuropathy (CAN). There is limited pathological evidence concerning cranial neuropathies, but clinical characteristics and behavior suggest that alternate mechanisms from microvasculitis need to be elucidated. Insight about common cranial neuropathies aids in counselling patients and allaying concerns by highlighting the favorable prognosis for recovery in most cranial neuropathies.
Authors of this chapter: Deepak Menon and Vera Bril.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Tesfaye S, Selvarajah D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev [Internet]. 2012 [cited 2021 Feb 18];28(S1):8–14. https://onlinelibrary.wiley.com/doi/abs/10.1002/dmrr.2239.
Boulton AJM, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care [Internet]. 2005 [cited 2021 Feb 17];28(4):956–62. https://care.diabetesjournals.org/content/28/4/956.
Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care [Internet]. 2003 [cited 2021 Apr 24];26(5):1553–79. https://care.diabetesjournals.org/content/26/5/1553.
Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester diabetic neuropathy study. Neurology. 1993;43(4):817–24.
O’Hare JA, Abuaisha F, Geoghegan M. Prevalence and forms of neuropathic morbidity in 800 diabetics. Ir J Med Sci [Internet]. 1994 [cited 2021 Feb 17];163(3):132–5. https://doi.org/10.1007/BF02965972.
Waite JH, Beetham WP. The visual mechanism in diabetes mellitus. N Engl J Med [Internet]. 1935 [cited 2021 Feb 18];212(9):367–79. https://doi.org/10.1056/NEJM193502282120901.
Watanabe K, Hagura R, Akanuma Y, Takasu T, Kajinuma H, Kuzuya N, et al. Characteristics of cranial nerve palsies in diabetic patients. Diabetes Res Clin Pract. 1990;10(1):19–27.
Al Kahtani ES, Khandekar R, Al-Rubeaan K, Youssef AM, Ibrahim HM, Al-Sharqawi AH. Assessment of the prevalence and risk factors of ophthalmoplegia among diabetic patients in a large national diabetes registry cohort. BMC Ophthalmol [Internet]. 2016 [cited 2021 Apr 2];16. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957375/.
Greco D, Gambina F, Pisciotta M, Abrignani M, Maggio F. Clinical characteristics and associated comorbidities in diabetic patients with cranial nerve palsies. J Endocrinol Invest [Internet]. 2012 [cited 2021 Feb 18];35(2):146–9. https://doi.org/10.3275/7574.
Trigler L, Siatkowski RM, Oster AS, Feuer WJ, Betts CL, Glaser JS, et al. Retinopathy in patients with diabetic ophthalmoplegia. Ophthalmology. 2003;110(8):1545–50.
Rush JA, Younge BR. Paralysis of cranial nerves III, IV, and VI. Cause and prognosis in 1000 cases. Arch Ophthalmol. 1981;99(1):76–9.
Richards BW, Jones FR, Younge BR. Causes and prognosis in 4,278 cases of paralysis of the oculomotor, trochlear, and Abducens cranial nerves. Am J Ophthalmol [Internet]. 1992 [cited 2021 Feb 18];113(5):489–96. https://www.sciencedirect.com/science/article/pii/S000293941474718X.
Keane JR. Multiple cranial nerve palsies: analysis of 979 cases. Arch Neurol [Internet]. 2005 [cited 2021 Feb 17];62(11):1714–7. https://doi.org/10.1001/archneur.62.11.1714.
Said G. Diabetic neuropathy—a review. Nat Clin Pract Neurol. 2007;3(6):331–40.
Lajmi H, Hmaied W, Ben Jalel W, Chelly Z, Ben Yakhlef A, Ben Zineb F, et al. Oculomotor palsy in diabetics. J Fr Ophtalmol. 2018;41(1):45–9.
Liu X, Xu Y, An M, Zeng Q. The risk factors for diabetic peripheral neuropathy: a meta-analysis. PLoS One [Internet]. 2019 [cited 2021 Feb 19];14(2). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382168/.
Said G. Focal and multifocal diabetic neuropathies. Arq Neuropsiquiatr [Internet]. 2007 [cited 2021 Feb 18];65(4B):1272–8. http://www.scielo.br/scielo.php?script=sci_abstract&pid=S0004-282X2007000700037&lng=en&nrm=iso&tlng=en.
Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL, et al. Diabetic neuropathy. Nat Rev Dis Primer [Internet]. 2019 [cited 2021 Feb 19];5(1):42. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096070/.
Acaroglu G, Akinci A, Zilelioglu O. Retinopathy in patients with diabetic ophthalmoplegia. Ophthalmology. 2008;222(4):225–8.
Lazzaroni F, Laffi GL, Galuppi V, Scorolli L. [Paralysis of oculomotor nerves in diabetes mellitus. A retrospective study of 44 cases]. Rev Neurol (Paris). 1993;149(10):571–573.
Goldstein JE, Cogan DG. Diabetic ophthalmoplegia with special reference to the pupil. Arch Ophthalmol. 1960;64:592–600.
Greco D, Gambina F, Maggio F. Ophthalmoplegia in diabetes mellitus: a retrospective study. Acta Diabetol [Internet]. 2008 [cited 2021 Feb 18];46(1):23. https://doi.org/10.1007/s00592-008-0053-8.
Dhume KU, Paul KE. Incidence of pupillary involvement, course of anisocoria and ophthalmoplegia in diabetic oculomotor nerve palsy. Indian J Ophthalmol [Internet]. 2013 [cited 2021 Feb 21];61(1):13–7. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554988/.
Jacobson DM. Pupil involvement in patients with diabetes-associated oculomotor nerve palsy. Arch Ophthalmol. 1998;116(6):723–7.
Shih MH, Huang FC, Tsai RK. Ischemic ophthalmoplegia in diabetic mellitus. Neuroophthalmology [Internet]. 2002 [cited 2021 Feb 20];26(3):181–91. https://doi.org/10.1076/noph.26.3.181.13974.
Dreyfus PM, Hakim S, Adams RD. Diabetic ophthalmoplegia; report of case, with postmortem study and comments on vascular supply of human oculomotor nerve. AMA Arch Neurol Psychiatry. 1957;77(4):337–49.
Smith BE, Dyck PJ. Subclinical histopathological changes in the oculomotor nerve in diabetes mellitus. Ann Neurol. 1992;32(3):376–85.
Asbury AK, Aldredge H, Hershberg R, Fisher CM. Oculomotor palsy in diabetes mellitus: a clinico-pathological study. Brain J Neurol. 1970;93(3):555–66.
Patel SV, Holmes JM, Hodge DO, Burke JP. Diabetes and hypertension in isolated sixth nerve palsy: a population-based study. Ophthalmology. 2005;112(5):760–3.
Wilker SC, Rucker JC, Newman NJ, Biousse V, Tomsak RL. Pain in ischemic ocular motor cranial nerve palsies. Br J Ophthalmol [Internet]. 2009 [cited 2021 Apr 2];93(12):1657–9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998753/.
Zrůstová M, Vrabec F, Rostlapil J. Diabetic changes of the extra-ocular muscles in man. Acta Diabetol Lat. 1979;16(1):55–62.
King AJ, Stacey E, Stephenson G, Trimble RB. Spontaneous recovery rates for unilateral sixth nerve palsies. Eye [Internet]. 1995 [cited 2021 Apr 2];9(4):476–8. https://www.nature.com/articles/eye1995110.
Ganesh S, Anilkumar SE, Narendran K. Botulinum toxin A in the early treatment of sixth nerve palsy in type 2 diabetes. Indian J Ophthalmol. 2019;67(7):1133–6.
Mollan SP, Edwards JH, Price A, Abbott J, Burdon MA. Aetiology and outcomes of adult superior oblique palsies: a modern series. Eye (Lond). 2009;23(3):640–4.
Dosunmu EO, Hatt SR, Leske DA, Hodge DO, Holmes JM. Incidence and etiology of presumed fourth cranial nerve palsy: a population-based study. Am J Ophthalmol [Internet]. 2018 [cited 2021 Apr 3];185:110–4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784757/.
McCaul JA, Cascarini L, Godden D, Coombes D, Brennan PA, Kerawala CJ. Evidence based management of Bell’s palsy. Br J Oral Maxillofac Surg. 2014;52(5):387–91.
Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of type 2 diabetes—global burden of disease and forecasted trends. J Epidemiol Glob Health [Internet]. 2020 [cited 2021 Mar 31];10(1):107–11. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310804/.
Fazeli Farsani S, van der Aa MP, van der Vorst MMJ, Knibbe CAJ, de Boer A. Global trends in the incidence and prevalence of type 2 diabetes in children and adolescents: a systematic review and evaluation of methodological approaches. Diabetologia [Internet]. 2013 [cited 2021 Mar 31];56(7):1471–1488. https://doi.org/10.1007/s00125-013-2915-z.
Korczyn AD. Bell’s palsy and diabetes mellitus. Lancet. 1971;1(7690):108–9.
Adour K, Wingerd J, Doty HE. Prevalence of concurrent diabetes mellitus and idiopathic facial paralysis (Bell’s palsy). Diabetes. 1975;24(5):449–51.
Korczyn AD. Prevalence of diabetes mellitus in Bell’s palsy. Lancet. 1971;2(7722):489.
Pecket P, Schattner A. Concurrent Bell’s palsy and diabetes mellitus: a diabetic mononeuropathy? J Neurol Neurosurg Psychiatry [Internet]. 1982 [cited 2021 Mar 31];45(7):652–5. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC491483/.
Zhao H, Zhang X, da Tang Y, Zhu J, Wang XH, Li ST. Bell’s palsy: clinical analysis of 372 cases and review of related literature. Eur Neurol [Internet]. 2017 [cited 2021 Mar 31];77(3–4):168–72. https://www.karger.com/Article/FullText/455073.
Tiemstra JD, Khatkhate N. Bell’s palsy: diagnosis and management. Am Fam Physician [Internet]. 2007 [cited 2021 Apr 1];76(7):997–1002. https://www.aafp.org/afp/2007/1001/p997.html.
Liston SL, Kleid MS. Histopathology of Bell’s palsy. Laryngoscope. 1989;99(1):23–6.
Pecket P, Schattner A. Concurrent Bell’s palsy and diabetes mellitus: a diabetic mononeuropathy? J Neurol Neurosurg Psychiatry. 1982;45(7):652–5.
Zhang W, Xu L, Luo T, Wu F, Zhao B, Li X. The etiology of Bell’s palsy: a review. J Neurol. 2020;267(7):1896–905.
Riga M, Kefalidis G, Danielides V. The role of diabetes mellitus in the clinical presentation and prognosis of Bell palsy. J Am Board Fam Med [Internet]. 2012 [cited 2021 Apr 1];25(6):819–26. https://www.jabfm.org/content/25/6/819.
Hohman MH, Hadlock TA. Etiology, diagnosis, and management of facial palsy: 2000 patients at a facial nerve center. Laryngoscope. 2014;124(7):E283–93.
Şevik Eliçora S, Erdem D. Does type 2 diabetes mellitus affect the healing of Bell’s palsy in adults? Can J Diabetes. 2018;42(4):433–6.
Eshbaugh CG, Siatkowski RM, Smith JL, Kline LB. Simultaneous, multiple cranial neuropathies in diabetes mellitus. J Neuroophthalmol. 1995;15(4):219–24.
Boulton AJM, Malik RA, Arezzo JC, Sosenko JM. Diabetic somatic neuropathies. Diabetes Care [Internet]. 2004 [cited 2021 Apr 8];27(6):1458–86. https://care.diabetesjournals.org/content/27/6/1458.
Kim SJ, Windon MJ, Lin SY. The association between diabetes and olfactory impairment in adults: a systematic review and meta-analysis. Laryngoscope Investig Otolaryngol [Internet]. 2019 [cited 2021 Apr 8];4(5):465–75. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6793600/.
Sadun AA. Neuro-ophthalmic manifestations of diabetes. Ophthalmology [Internet]. 1999 [cited 2021 Apr 23];106(6):1047–1048. https://www.aaojournal.org/article/S0161-6420(99)90242-7/abstract.
Medlej R, Wasson J, Baz P, Azar S, Salti I, Loiselet J, et al. Diabetes mellitus and optic atrophy: a study of Wolfram syndrome in the Lebanese population. J Clin Endocrinol Metab. 2004;89(4):1656–61.
Gian PG, Ama S, Peter YC, Rafael TC. Diabetic papillopathy: current and new treatment options. Curr Diabetes Rev [Internet]. 2011 [cited 2021 Apr 22];7(3):171–5. https://www.eurekaselect.com/74265/article.
Hayreh SS. Diabetic papillopathy and nonarteritic anterior ischemic optic neuropathy. Surv Ophthalmol. 2002;47(6):600–2; author reply 602.
Chen T, Song D, Shan G, Wang K, Wang Y, Ma J, et al. The association between diabetes mellitus and nonarteritic anterior ischemic optic neuropathy: a systematic review and meta-analysis. PLoS One [Internet]. 2013 [cited 2021 Apr 23];8(9):e76653. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0076653.
Hayreh SS, Zimmerman MB. Nonarteritic anterior ischemic optic neuropathy: clinical characteristics in diabetic patients versus nondiabetic patients. Ophthalmology [Internet]. 2008 [cited 2021 Apr 23];115(10):1818–25. https://www.sciencedirect.com/science/article/pii/S0161642008003047.
Xu Z, Zhang P, Long L, He H, Zhang J, Sun S. Diabetes mellitus in classical trigeminal neuralgia: a predisposing factor for its development. Clin Neurol Neurosurg. 2016;151:70–2.
Takayama S, Osawa M, Takahashi Y, Iwamoto Y. Painful neuropathy with trigeminal nerve involvement in type 2 diabetes. J Int Med Res. 2006;34(1):115–8.
Zhang A, Zhang W, Xu H, Guo C, Yuan L, Xu Y, et al. Diabetes mellitus contributes to carbamazepine resistance in patient with trigeminal neuralgia. Neurosurg Rev [Internet]. 2020 [cited 2021 Apr 8]. https://doi.org/10.1007/s10143-020-01304-4.
Baiduc RR, Helzner EP. Epidemiology of diabetes and hearing loss. Semin Hear. 2019;40(4):281–91.
Matsumoto F, Momota Y, Takano H, Matsuka Y. Glossopharyngeal neuralgia caused by diabetes mellitus: a case report. Jpn J Orofac Pain. 2016;9(1):81–5.
Pop-Busui R. Cardiac autonomic neuropathy in diabetes. Diabetes Care [Internet]. 2010 [cited 2021 Apr 8];33(2):434–41. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809298/.
Yu Y, Hu L, Xu Y, Wu S, Chen Y, Zou W, et al. Impact of blood glucose control on sympathetic and vagus nerve functional status in patients with type 2 diabetes mellitus. Acta Diabetol. 2020;57(2):141–50.
Berry H, Blair RL. Isolated vagus nerve palsy and vagal mononeuritis. Arch Otolaryngol [Internet]. 1980 [cited 2021 Apr 8];106(6):333–8. https://europepmc.org/article/med/7378018.
Mathew J, Mohan M, Menon A. Multiple cranial neuropathies in a patient with diabetes mellitus. Ann Indian Acad Neurol [Internet]. 2019 [cited 2021 Apr 8];22(3):353–5. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613403/.
Sommer DD, Freeman JL. Bilateral vocal cord paralysis associated with diabetes mellitus: case reports. J Otolaryngol. 1994;23(3):169–71.
Ravi R, Gunjawate DR. Effect of diabetes mellitus on voice: a systematic review. Pract Diabetes. 2019;36(5):177–80.
Kenmegne C, Kamdem F, Jingi AM, Choukem SP. Hypoglossal nerve paralysis revealing type 2 diabetes mellitus: a case report. Rev Méd Pharm. 2016;6(2):617–21.
Benarroch EE. Physiology and pathophysiology of the autonomic nervous system. Continuum (Minneap Minn). 2020;26(1):12–24.
Coon EA, Cheshire WP. Sweating disorders. Continuum (Minneap Minn). 2020;26(1):116–37.
Pittasch D, Lobmann R, Behrens-Baumann W, Lehnert H. Pupil signs of sympathetic autonomic neuropathy in patients with type 1 diabetes. Diabetes Care [Internet]. 2002 [cited 2021 Apr 4];25(9):1545–50. https://care.diabetesjournals.org/content/25/9/1545.
López-Pintor RM, Casañas E, González-Serrano J, Serrano J, Ramírez L, de Arriba L, et al. Xerostomia, hyposalivation, and salivary flow in diabetes patients. J Diabetes Res [Internet]. 2016 [cited 2021 Apr 3];2016. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958434/.
Moore PA, Guggenheimer J, Etzel KR, Weyant RJ, Orchard T. Type 1 diabetes mellitus, xerostomia, and salivary flow rates. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;92(3):281–91.
Watkins PJ. Facial sweating after food: a new sign of diabetic autonomic neuropathy. Br Med J [Internet]. 1973 [cited 2021 Apr 3];1(5853):583–7. https://www.bmj.com/content/1/5853/583.
Shaw JE, Parker R, Hollis S, Gokal R, Boulton AJ. Gustatory sweating in diabetes mellitus. Diabet Med. 1996;13(12):1033–7.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Menon, D., Bril, V. (2023). Diabetic Cranial Neuropathies. In: The Cranial Nerves in Neurology. Springer, Cham. https://doi.org/10.1007/978-3-031-43081-7_20
Download citation
DOI: https://doi.org/10.1007/978-3-031-43081-7_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-43080-0
Online ISBN: 978-3-031-43081-7
eBook Packages: MedicineMedicine (R0)